Remove Article Remove FDA Remove Labelling
article thumbnail

Top 10 Journal Articles To Read During Your Infectious Diseases Pharmacy Rotation

IDStewardship

In this post a top 10 list of journal articles to read during an infectious diseases pharmacy rotation is provided. Articles included here are some of my favorites. Not being included in this list does not reflect a lack of quality and certainly there are many robust articles that could be added. Authored by: Timothy P.

article thumbnail

15 Antibiotic Myths To Beware

IDStewardship

In this article an infectious diseases pharmacist discusses antibiotic myths. Article posted 27 October 2022. Here is an article in BMJ that details the topic. ” New antibiotics coming to the market must have a reasonable degree of safety and efficacy to achieve FDA-approval. Authored by: Timothy P. BCPS, BCIDP.

Labelling 364
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Review of 3 Alternative Pathways to Access Non–FDA-Approved Drugs

Pharmacy Times

Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.

FDA 94
article thumbnail

Tirzepatide vs. semaglutide: Differences & similarities explained

The Checkup by Singlecare

Note that while there are compounded versions of tirzepatide and semaglutide , these drugs are not FDA approved. This article focuses on the five FDA-approved versions of tirzepatide and semaglutide. Tirzepatide is the active ingredient in two medications approved by the Food and Drug Administration (FDA).

article thumbnail

From GRP to SIUU – the Evolution of FDA Guidance on Off-Label Dissemination of Scientific Information

The FDA Law Blog

By Dara Katcher Levy — Yesterday, FDA published a new Draft Guidance, “ Communications from Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Questions and Answers ” (SIUU Guidance or Draft Guidance).

article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled.

FDA 97
article thumbnail

STAT+: Pharmalittle: We’re reading about fake Ozempic, the FTC policing pharma, and more

STAT

Ozempic and similar diabetes medicines have been increasingly used off label for weight loss. The FDA has been looking into 22 cases of T-cell cancers that occurred after treatment with CAR-T, Reuters notes, citing an article published in The New England Journal of Medicine by two FDA officials.

Labelling 108